雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Outcome of intravitreal injection of bevacizumab for branch retinal vein occlusion Tatsuya Yunoki 1 , Sachiko Takeda 1 , Kazuya Fujita 1 , Keiichi Mitarai 1 , Kiyotaka Kitagawa 1 , Shuichiro Yanagisawa 1 , Kazuhiko Watanabe 1 , Miharu Mihara 1 , Atsushi Hayashi 1 1Dept of Ophthalmol,Grad Sch of Med and Pharmaceutical Sci,Univ of Toyama pp.679-682
Published Date 2009/5/15
DOI https://doi.org/10.11477/mf.1410102702
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the outcome of intravitreal injection of bevacizumab for branch retinal vein occlusion(BRVO). Cases and Method:This study was made on 34 eyes of 34 patients with BRVO. The series comprised 10 males and 24 females. The age averaged 70 years. Each eye received intravitreal injection of 1.25 mg bevacizumab. Cases were followed up for 6 months or longer. Change in logMAR visual acuity by 0.3 or more was judged as improvement or deterioration. Results:Visual acuity improved in 20 eyes(59%). Foveal thickness averaged 532±216μm before and 315±144μm after treatment. The difference was significant(p<0.01). Macular edema recurred in 27 eyes(79%). Treatment with bevacizumab was repeated in 19 eyes(56%). Macular photocoagulation was performed in 14 eyes(41%). Conclusion:Intravitreal injection of bevacizumab is effective for BRVO on a short-term basis.


Copyright © 2009, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有